Cell & Gene Therapy Supply Management with PCI Pharma Services
More Content From Cell & Gene Therapy Supply Management with PCI Pharma Services
-
Expediting Clinical Trials
Mitigate potential delays while awaiting IND approval with a Pre-IND strategy.Sponsored Content Released on 05.06.2021
-
Six Strategies to Stretch Your Limited Drug Supply for Clinical Studies
The following six strategies can be used to find balance; nevertheless, they all require the support of a trusted clinical packager.White Papers / Tech Papers Released on 09.16.2020
-
Rapidly Switching to Direct-to-Patient Protocols
Water Cooler ChatWhite Papers / Tech Papers Released on 09.07.2020
-
EU Good Manufacturing Practice - ANNEX 13
Investigational Medicinal ProductsWhite Papers / Tech Papers Released on 09.04.2020
-
Kohlberg and Mubadala sign a definitive agreement to acquire majority stake in PCI Pharma Services
...News Releases Released on 08.24.2020
-
Importing Clinical Supplies into China
Water Cooler ChatWhite Papers / Tech Papers Released on 08.13.2020
-
EU Compassionate Use Programs - Where’s My Drug?
Water Cooler ChatWhite Papers / Tech Papers Released on 08.05.2020
-
Introduction to PCI Drug Development and Manufacturing Services
...Literature / Brochures Released on 07.30.2020
-
PCI Pharma Services Announces Global Expansion of Clinical Trial Services
PCI Broadens Global Clinical Supply-Chain Service Offerings Into Mainland EuropeNews Releases Released on 07.28.2020
-
Importing Clinical Supplies into Japan
Water Cooler ChatWhite Papers / Tech Papers Released on 07.23.2020
-
Multimillion Dollar Investment Firmly Establishes Commercial Operations Globally to Support Business
PCI Pharma Services Announces Completion of Biotech Center of Excellence in Philadelphia and Expansions to Biotech Capabilities in EuropeNews Releases Released on 06.29.2020
Related Content
